MUTYH- associated polyposis: Is it time to change upper gastrointestinal surveillance? A single-center case series and a literature overview
- PMID: 38077639
- PMCID: PMC10701228
- DOI: 10.4251/wjgo.v15.i11.1891
MUTYH- associated polyposis: Is it time to change upper gastrointestinal surveillance? A single-center case series and a literature overview
Abstract
Background: The presence of Spigelman stage (SS) IV duodenal polyposis is considered the most significant risk factor for duodenal cancer in patients with MUTYH-associated polyposis (MAP). However, advanced SS disease is rarely reported in MAP patients, and no clear recommendations on small bowel (SB) surveillance have been proposed in this patient setting.
Aim: To research more because that case reports of duodenal cancers in MAP suggest that they may develop in the absence of advanced benign SS disease and often involve the distal portion of the duodenum.
Methods: We describe a series of MAP patients followed up at the Regina Elena National Cancer Institute of Rome (Italy). A literature overview on previously reported SB cancers in MAP is also provided.
Results: We identified two (6%) SB adenocarcinomas with no previous history of duodenal polyposis. Our observations, supported by literature evidence, suggest that the formula for staging duodenal polyposis and predicting risk factors for distal duodenum and jejunal cancer may need to be adjusted to take this into account rather than focusing solely on the presence or absence of SS IV disease.
Conclusion: Our study emphasizes the need for further studies to define appropriate upper gastrointestinal surveillance programs in MAP patients.
Keywords: Case report; Duodenal adenomatosis; Duodenal cancer; Endoscopic management; MUTYH-associated polyposis.
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Figures

References
-
- Al-Tassan N, Chmiel NH, Maynard J, Fleming N, Livingston AL, Williams GT, Hodges AK, Davies DR, David SS, Sampson JR, Cheadle JP. Inherited variants of MYH associated with somatic G:C-->T:A mutations in colorectal tumors. Nat Genet. 2002;30:227–232. - PubMed
-
- Patel R, McGinty P, Cuthill V, Hawkins M, Moorghen M, Clark SK, Latchford A. MUTYH-associated polyposis - colorectal phenotype and management. Colorectal Dis. 2020;22:1271–1278. - PubMed
-
- Nielsen M, Morreau H, Vasen HF, Hes FJ. MUTYH-associated polyposis (MAP) Crit Rev Oncol Hematol. 2011;79:1–16. - PubMed
-
- Kanth P, Grimmett J, Champine M, Burt R, Samadder NJ. Hereditary Colorectal Polyposis and Cancer Syndromes: A Primer on Diagnosis and Management. Am J Gastroenterol. 2017;112:1509–1525. - PubMed
-
- Yang J, Gurudu SR, Koptiuch C, Agrawal D, Buxbaum JL, Abbas Fehmi SM, Fishman DS, Khashab MA, Jamil LH, Jue TL, Law JK, Lee JK, Naveed M, Qumseya BJ, Sawhney MS, Thosani N, Wani SB, Samadder NJ. American Society for Gastrointestinal Endoscopy guideline on the role of endoscopy in familial adenomatous polyposis syndromes. Gastrointest Endosc. 2020;91:963–982.e2. - PubMed
LinkOut - more resources
Full Text Sources